Breast care · Precise diagnostics · Grade III Class A
Breast cancer treatment in China
Breast cancer is several different subtypes, and treatment depends on an accurate diagnosis. Here's what methods exist and why it all starts with molecular testing of the tumor.
Breast cancer is several diseases under one name
Breast cancer has several subtypes, and treatment depends directly on the subtype. So the key to outcomes is not a "one-size-fits-all" regimen but accurate diagnostics: a biopsy with immunohistochemistry that determines hormone status and HER2, plus imaging.
For assessment, biopsy results with immunohistochemistry and scans in DICOM format are needed — they form the basis of a personal strategy.
Which methods are used
Surgery — including breast-conserving surgery where possible
Radiation therapy and radiosurgery — including CyberKnife as indicated
Chemotherapy
Targeted and hormone therapy — by tumor subtype; some drugs are available through the Hong Kong–Macao program
A careful approach to outcomes
Modern breast cancer treatment aims to combine effectiveness with preserving quality of life — hence breast-conserving surgery and precise radiation methods. What suits you is determined by the board after reviewing the tumor subtype.
Why FFCH
Foshan Fosun Chancheng Hospital is a hospital Grade III Class A with a multidisciplinary board where surgery, radiation methods and drug therapy work together. For international patients — interpreters, visa help, and documents for your doctor at home.
Frequently asked questions
Which breast cancer treatments are available at FFCH?
A combination: surgery (including breast-conserving), radiation therapy and radiosurgery, chemotherapy, plus targeted and hormone therapy based on molecular testing of the tumor. The regimen is determined by the board.
Can the breast be preserved during surgery?
In many cases breast-conserving surgery is possible — this is decided individually, depending on the size and location of the tumor. The aim of the modern approach is effective treatment with the most tissue-sparing outcome.
Why is molecular testing of the tumor needed?
Breast cancer has different subtypes (for example, hormone-dependent, HER2-positive). Testing determines the subtype and indicates which targeted or hormone drugs will suit. Some of these drugs are available through the Hong Kong–Macao program.
Which documents should I send?
Records, biopsy results with immunohistochemistry, mammography/ultrasound/MRI and scans in DICOM format. The fuller the data, the more accurate the preliminary assessment.
How do I start?
Send your documents to the FFCH representative on Telegram @kolokolova_eo — within 48 hours you'll receive an assessment and a personal protocol with an estimate.
Official representative of Foshan Fosun Chancheng Hospital (FFCH). She supports patients at every stage — from reviewing documents to returning home.
This material is for reference only and does not replace a doctor's consultation. The breast cancer treatment regimen is determined by the board after reviewing the tumor subtype and scans.